Element List |
Explanation |
The reason of the increase (decrease) in the net profit during the current quarter compared to the same quarter of the last year is |
The achieved net income is mainly attributable to higher average selling prices and increase in the share of results of joint ventures and associates. Noting that in 2Q 2020, there was impairment provisions in certain capital assets amounted to SR 1.18 billion. |
The reason of the increase (decrease) in the net profit during the current quarter compared to the previous period of the current year is |
The increase in net income is mainly attributable to higher average selling prices of most products and higher sales volume in addition to the increase in share of results of joint ventures and associates. |
The reason of the increase (decrease) in the net profit during the current period compared to the same period of the last year is |
The achieved net income is mainly attributable to higher average selling prices and increase in the share of results of joint ventures and associates. Noting that during the first half of 2020, there were impairment provisions in certain capital and financial assets amounted to SR 2.28 billion. |
Statement of the type of external auditor's report |
Unmodified conclusion |
Reclassification of Comparison Items |
-Certain prior period figures have been re-classified to conform with the presentation in the current period. -Reference to our announcement of 3Q 2020 results, the shareholders equity attributable to SABIC as at January 1st, 2020 has been adjusted and reclassified to non-current financial liabilities by SR 706 million as a result of applying a different policy choice to account for the derivatives on equity instruments for its forward contracts related to certain subsidiaries |
Additional Information |
- On January 1st 2021, SABIC has early adopted the amendment to IAS 16-– ‘Property, Plant and Equipment: Proceeds before Intended Use’. - Attached 2Q 2021 earnings release and presentation |
Attached Documents |
|
Comments